Hépato-Gastro & Oncologie Digestive
Volume 19, issue 4, Avril 2012
Éditorial
Immunosuppressive therapy and cancers in inflammatory bowel disease or how to take into account the benefit-risk ratio in our clinical practice?
(p.227-9)
Laurent Peyrin-Biroulet
Free Access
Mini-revue
Radioembolization of primary and secondary liver tumors
(p.231-8)
Olivier Dubreuil, Aziz Zaanan, Isabelle Trouilloud, Marc Sapoval, Olivier Pellerin, Sameh Awad, Nadia Ghazzar, Céline Lepère, Philippe Rougier, Julien Taieb
Free Access
MSI colon cancer: is adjuvant therapy warranted?
(p.242-7)
Aziz Zaanan, Olivier Dubreuil, Isabelle Trouilloud, Pierre Laurent-Puig, Julien Taieb
Free Access
Evolution of practices and factual results of liver transplantation for alcoholic liver disease
(p.248-53)
Amélie Cannesson, Guillaume Lassailly, Emmanuel Boleslawski, Alexandre Louvet, Philippe Mathurin, François René Pruvot, Sébastien Dharancy
Free Access
Clinical implications of diabetes mellitus in cirrhosis
(p.254-62)
Pauline Houssel, Richard Moreau, Laure Elkrief
Free Access
Dyschezia: from diagnostic to treatment
(p.263-71)
Véronique Vitton, Henri Damon, Jean-Luc Faucheron
Free Access
Screening of biliary and liver diseases in inflammatory bowel disease. Consequences on the therapeutic management
(p.272-9)
Stéphane Nancey, Gilles Boschetti, Bernard Flourié
Free Access
Concepts et Pratique
Acute severe alcoholic hepatitis: good news from France!
(p.280-4)
Alexandre Pariente
Free Access
Fecal tranplantation: new therapy for recurrent Clostridium difficile infection?
(p.285-8)
Frédérique Maire
Free Access
Infos-PRO
Une loi de circonstance
(p.289-90)
Philippe Godeberge
Free Access
Agenda
Agenda
(p.291-2)
Free Access
Injections de rappel
Injections de rappel
(p.293-4)
Free Access